whiteguardian
Credits:
9523
My Scrapbook
|
|
03.23.06 (2 years ago)
#2
|
|
* Physostigmine, given as an atropine antidote by slow intravenous injection of 1 to 4 mg (0.5 to 1.0 mg in children), rapidly abolishes delirium and coma caused by large doses of atropine in most situations.
Since physostigmine has a short duration of action, the patient may again lapse into coma after one or two hours and repeated doses are likely to be required.
Neostigmine, pilocarpine and methacholine are of little real benefit, since they do not penetrate the blood-brain barrier
|
|
rajponn
Credits:
4434
My Scrapbook
|
CMDT 2005
|
05.10.06 (2 years ago)
#3
|
|
ATROPINE & ANTICHOLINERGICS
Atropine, scopolamine, belladonna, diphenoxylate with atropine, Datura stramonium, Hyoscyamus niger, some mushrooms, tricyclic antidepressants, and antihistamines are antimuscarinic agents with variable central nervous system effects. The patient complains of dryness of the mouth, thirst, difficulty in swallowing, and blurring of vision. The physical signs include dilated pupils, flushed skin, tachycardia, fever, delirium, myoclonus, ileus, and flushed appearance. Antidepressants and antihistamines may induce convulsions.
Antihistamines are commonly available with or without prescription. Diphenhydramine commonly causes delirium, tachycardia, and seizures. Massive overdose may mimic tricyclic antidepressant poisoning. The first-generation “nonsedating” agents terfenadine and astemizole caused QT interval prolongation and torsade de pointes (atypical ventricular tachycardia) and were removed from the United States market. Loratadine and fexofenadine have not caused this problem.
Treatment
A. EMERGENCY AND SUPPORTIVE MEASURES
Administer activated charcoal (see p 1612). Tepid sponge baths and sedation are indicated to control high temperatures (see p 1610).
B. SPECIFIC TREATMENT
For pure atropine or related anticholinergic syndrome, if symptoms are severe (eg, hyperthermia or excessively rapid tachycardia), give physostigmine salicylate, 0.5–1 mg slowly intravenously over 5 minutes, with electrocardiographic monitoring, until symptoms are controlled. Bradyarrhythmias and convulsions are a hazard with physostigmine administration, and it should not be used in patients with tricyclic antidepressant overdose.
| Quote: |
| GOD GRANT ME THE STRENGTH TO CHANGE WHAT I CAN , THE COURAGE TO BEAR WHAT I CANNOT CHANGE, AND THE WISDOM TO KNOW THE DIFFERENCE. |
|
|